Order byBest matchMost fresh

FDA will OK updated COVID vaccines for some

Digest more
Top News
Overview
Impacts
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials
Vaccine manufacturers will need to conduct "randomized, placebo-controlled trials" before the FDA will approve future applications to give shots to "all healthy persons" between the ages of 6 months ...

Continue reading

FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
What to know about the FDA plan to restrict COVID vaccines
WA vaccine scientists push back against FDA changes around COVID shots
Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

Continue reading

FDA tightens requirements for COVID vaccine, adding trials for healthy adults
F.D.A. Poised to Restrict Access to Covid Vaccines
FDA sets new COVID booster guidelines for healthy adults under 65
Vaccine makers have argued that because COVID vaccines have been changed annually to match the circulating strain of the virus, new placebo-controlled trials could delay availability of the shots unt...

Continue reading

FDA may limit future Covid-19 shots to older people and those at risk of serious infection
Las Vegas Sun · 1d
RFK Jr. pledged not to upend US vaccine system, but big changes are underway
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
Fierce Biotech4h
Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data
Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win approval in adults aged 50 and older in November 2025. However, at the start of May, Moderna pushed back the expected approval date to 2026 after the FDA asked to see phase 3 efficacy before making a decision on authorization.
FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
Feedback